Monthly Archives: March 2021

Four problems with the lab origin hypothesis of SARS-CoV-2 and the WHO-China study

By on .

By Daniel R. Lucey MD, MPH, FIDSA Today the Joint WHO-China Study 14 January-10 February 2021 for the “WHO-convened Global Study of origins of SARS-CoV-2: China Part” was posted on the World Health Organization’s website.  Zero patients with COVID were reported before December 8, 2021, yet 174 patients were found between Dec. 8 to 31, […]

As Variant B.1.427/B.1.429 spreads in California, Nevada and Arizona, HHS stops direct ordering of the monoclonal Bamlanivimab

By on .

By Daniel R. Lucey MD, MPH, FIDSA The United States Centers for Disease Control and Prevention this month has provided helpful updates on its website focusing on SARS-CoV-2 variants and their prevalence state-by-state. This information helps clinicians understand where variants are as well as make decisions on use of monoclonal antibodies that have U.S. Food […]

“The mutating H5N8 strain of avian flu has a high risk of human-to-human transmission” Russian authorities warn March 12.   

By on .

By Daniel R. Lucey MD, MPH, FIDSA On Feb. 20, 2021 Russia reported the first-ever human infections with H5N8 avian influenza involving seven poultry farm workers in the southern region of Astrakhan Oblast.  They were infected after a Dec. 3-11, 2020 outbreak of H5N8 on a poultry farm. Although Russia reported a government lab was […]

Will the next “WHO-convened Global Study of the origins of SARS-CoV-2” be in SE Asia, Europe, or the Americas?

By on .

By Daniel R. Lucey MD, MPH, FIDSA By July 31, 2020 the World Health Organization and China had agreed in writing to a highly-consequential document with long-term implications titled “WHO-convened Global Study of the Origins of SARS-CoV-2: Terms of References for the China Part”. This title, as well as multiple statements in the text such […]

First multivalent vaccine with a variant (B.1.351) begins: Will it protect against other E484K variants?

By on .

By Daniel R. Lucey MD, MPH, FIDSA On March 10 Moderna announced that it had begun vaccinating volunteers in a study of 60 persons previously “vaccinated with mRNA-1273 to receive a single booster dose of either: 20 µg of a variant-specific booster candidate, mRNA-1273.351, based on the B.1.351 variant first identified in the Republic of South Africa (N=20) […]

Why did the WHO-China team call the lab origin hypothesis “extremely unlikely” when their “Terms of References” did not mention it at all?

By on .

By Daniel R. Lucey MD, MPH, FIDSA Following the May 2020 World Health Assembly resolution 73.1 regarding COVID-19 (item 6 on page 6), the World Health Organization and China agreed in writing in a July 31 July 2020 document titled “WHO-convened Global Study of the Origins of SARS-CoV-2 ‘Terms of References for the China Part‘”. […]

Virtual CROI 2021: From COVID-19 testing to death, toll of the inverse care law continues, Swiss study finds

By on .

Fifty years almost to the day after British physician Julian Tudor Hart described “The Inverse Care Law” in a Lancet article, a coronavirus unheard of until little more than a year ago is demonstrating the concept in action, a study in Switzerland presented at CROI today shows. The Inverse Care Law, Dr. Hart wrote then, is in […]

Virtual CROI 2021: Disparate impacts of two pandemics highlight systemic and leadership failures across four decades

By on .

As the AIDS epidemic emerged and spread in 1981, its swift and steep death toll raising urgent needs for answers and action, it was met at first with silence, a speaker at today’s virtual CROI noted. President Reagan did not acknowledge the pandemic or say the word AIDS until 1987, while other officials spoke of […]

Virtual CROI 2021: In opening talk Dr. Fauci looks at the “two-way street” of lessons from HIV and COVID-19

By on .

Transmitted by people without symptoms, hitting populations regarded too widely as “disposable,” its spread facilitated by claims the deadly public health threat is a hoax, and presenting lessons in research that include the critical roles of community engagement and of collaborative endeavors reaching across disciplines and national boundaries, HIV offered valuable lessons to scientists and […]